Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 30 filings·Updated 29 Sept 2026
Showing 10 of 30 filings.
29 Sept 20262 filings
AGM/EGMAGM

National Peroxide Ltd 6th AGM approves FY2026 financials, dividend, director reappointment and audits via VC/OAVM

AGM Details

  • Date and time: Sep 29, 2026 at 11:00 IST via VC/OAVM.
  • Remote e-voting window: Sep 26–28, 2026.
  • Record/cut-off date: Sep 9, 2026.
  • Scrutinizer: Nilesh Shah & Associates.

Key Resolutions & Outcomes

  • Adopted Audited Financial Statements for FY ended 31 Mar 2026; approved.
  • Final dividend of Rs 7.00 per equity share approved.
  • Ness N. Wadia reappointed by rotation; approved.
  • Statutory Auditors reappointed for FY 2026-27; approved.
  • Cost Auditor remuneration for FY 2026-27 ratified.
  • Remuneration of Directors for FY 2026-27 approved.

Dividend

  • Dividend per share: Rs 7.00.

Director Changes

  • Ness N. Wadia reappointed by rotation.

Auditors

  • Statutory Auditor: Kalyaniwalla & Mistry LLP reappointed for FY 2026-27.
  • Cost Auditor remuneration approved for FY 2026-27.

RPT & Other Approvals

  • Material related party transactions: None disclosed.
  • Other material approvals: none.
Filed 20:35View Source
AGM/EGMAGM

National Peroxide's 6th AGM via VC approves dividend and appoints auditors; voting results pending

AGM Details

  • AGM held September 29, 2026 at 11:00 IST via VC/OAVM.
  • Concluded at 12:00 IST; deemed venue: Mumbai registered office.
  • Remote e-voting: Sep 26–28, 2026; results to be announced by Oct 1, 2026.

Resolutions

  • Resolution 1 (Ordinary): Adoption of Audited Financial Statements and Reports; results pending.
  • Resolution 2 (Ordinary): Final dividend of Rs. 7.00 per equity share.
  • Resolution 3 (Ordinary): Reappointment of Ness N Wadia by rotation.
  • Resolution 4 (Ordinary): Reappointment of Statutory Auditors: M/s Kalyaniwalla & Mistry LLP.
  • Resolution 5 (Ordinary): Ratification of remuneration to Cost Auditors for FY 2026-27.
Filed 20:10View Source
24 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

National Peroxide Limited: Trading Window Closed from October 01, 2026 until 48 hours after the declaration of the unaudited financial results for the quarter and half year ending September 30, 2026

National Peroxide Limited: Trading Window Closed from October 01, 2026 until 48 hours after the declaration of the unaudited financial results for the quarter and half year ending September 30, 2026

Filed 16:51View Source
5 Sept 20261 filing
Company UpdateNewspaper Publication

Please find enclosed herewith Newspaper Publication regarding Annual General Meeting of the Company.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 14:00View Source
3 Sept 20262 filings
Company UpdateGeneral

National Peroxide schedules 6th AGM via VC/OAVM on Sep 29, 2026; shares annual report link and KYC reminders

AGM details

  • Sixth AGM of National Peroxide Limited (formerly NPL Chemicals) on 29 Sep 2026 at 11:00 IST via VC/OAVM.

Annual report access

  • Annual Report for FY 2025-26 available on the company site and via the AGM notice link.

Email registration

  • Letters issued to members without registered emails, with the AGM notice web-link.

KYC / dematerialisation

  • Reminder to update KYC details per SEBI circular; Aug 28, 2026 cut-off date.

RTA / contact

  • MUFG Intime India Private Limited is the Registrar & Transfer Agent for queries.
Filed 20:05View Source
OthersReg. 34 (1) Annual Report

National Peroxide Limited reports FY2025-26 revenue ₹29,568.37 lakh; PAT ₹582.42 lakh; restatement due to gas invoicing; final dividend ₹7/sh; hydrogen peroxide expansion underway

Financial performance

  • Total Income rose to ₹29,568.37 lakh in FY2025-26.
  • EBITDA rose to ₹30.21 crore from ₹19.70 crore.
  • PAT ₹582.42 lakh, reversing prior-year loss ₹224.64 lakh.
  • EPS ₹10.13; FY2024-25 EPS ₹-3.91.
  • Final dividend ₹7 per equity share proposed; AGM approval required.
  • Cash and cash equivalents ₹1,880.17 lakh at 31 Mar 2026.
  • Total debt ₹1,271.42 lakh; net debt to equity 0.00%.
  • Restatement: gas invoicing error corrected; FY2026 restated per Note 48.

Operations & capacity

  • Hydrogen peroxide capacity at Kalyan: 150,000 MTPA (50% w/w).
  • PV Grade Hydrogen Peroxide launched for solar/semiconductor use.
  • Product portfolio includes Hydrogen Peroxide, Compressed Hydrogen Gas, Peracetic Acid.
  • Exports expanding; opportunities in EVs, renewables, semiconductors.
  • Integrated manufacturing infra supports consistent product quality and efficiency.

Governance & risk

  • Board comprises six directors: 1 Executive, 2 Non-Executive, 3 Independent.
  • Statutory auditors re-appointed: Kalyaniwalla & Mistry LLP for five years.
  • Internal auditors: PKF Sridhar & Santhanam; Cost auditors: D.C. Dave & Co.
  • Executive leadership: Rajiv Arora as CEO; KMP changes in FY2025-26.
  • Independent Directors declarations; annual board evaluation conducted.

Dividend & capital

  • Final dividend proposed: ₹7 per share; payout ratio 69.07% of net profit.
  • Record date for dividend entitlement: 22 Sep 2026.
  • Dividend payable after AGM, subject to shareholder approval.

CSR & ESG

  • CSR spend ₹38.94 lakh; two projects with Ness Wadia Foundation and NamMyoho Daan.
  • CSR policy available on company website.

Restatement & audit remarks

  • Note 48 documents restatement due to gas invoicing error in FY2026.
  • Restated cost of raw materials ₹694.63 lakh; revised EPS ₹10.13.

Risks & outlook

  • Risks: volatility in raw materials and energy, FX exposure, supply chain disruptions.
  • Outlook: positive long-term demand for sustainable chemicals; export expansion.
Filed 19:58View Source
1 Sept 20261 filing
Company UpdateNewspaper Publication

Please find enclosed herewith Newspaper Publication regarding Annual General meeting of the Company.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 18:28View Source
13 Aug 20261 filing
Company UpdateNewspaper Publication

Please find attached Copies of Newpaper Publication of the Extract of the Revised Audited Financial Results for the Quarter & year ended March 31, 2026, and Unaudited Financial results ....

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 12:38View Source
12 Aug 20261 filing
Corp. ActionBook Closure

National Peroxide schedules 6th AGM on Sept 29, 2026; book closure and dividend details

AGM, book closure and dividend

  • AGM to be held on September 29, 2026 via video conference/AV.
  • Book closure for AGM and final dividend from September 23 to September 29, 2026 (inclusive).
  • Record date for AGM and final dividend fixed at September 22, 2026.
  • Final dividend recommended at 70% (₹7 per equity share of ₹10), subject to member approval.
  • Dividend payment, if declared, will be made within applicable statutory timelines.
  • Security affected: equity shares of ₹10 face value.
Filed 13:27View Source
9 Aug 20261 filing
Board Meeting

National Peroxide Board to consider revised March 2026 results and June 2026 unaudited results on Aug 12, 2026.

Meeting Details

  • Board meeting scheduled for August 12, 2026; time and venue not disclosed.

Key Agenda Items

  • Revised Audited Financial Results for quarter and year ended March 31, 2026; Revised Audited Financial Statements.
  • Un-audited Financial Results for the quarter ended June 30, 2026.
Filed 17:46View Source
Showing 10 of 30 filings